Science - Our Universal Language
Hotel Hesperia Tower - Hyatt
18 - 20 November 2020
Covid-19 statement at bottom of this page
EBF was founded in 2006 at the initiative of 12 pharmaceutical companies, all of them having bioanalytical lab activities in Europe. The goal of bringing these companies together was to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and last but not least regulatory issues. Until 2010, EBF membership was limited to companies involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. From 2011 onwards, the EBF welcomed CROs involved in bioanalytical activities in a pharmaceutical research and development environment in Europe. Currently, the EBF counts 66 members (October 2019). Since 2010, the EBF became a non-profit organisation (vzw) established pursuant to the Belgian Act of 27 June 1921 on non-profit associations, international non-profit associations and foundations.
EBF organizes three meeting formats
Focus Workshops: these 1-1.5 days workshops are organized around themes of high or urgent interest for the EBF community or to connect the EBF with adjacent disciplines to create synergy or learn. Themes may be scientific or process related. Focus Workshops are non-sponsored meetings. They are mostly organized within a relatively short lead time and have a frequency of 2 times/year (one in spring http://springfocus.e-b-f.eu and one in autumn http://autumnfocus.e-b-f.eu/ ).
Open Symposium: Ever since 2008, the EBF organizes a yearly Open Symposium in the 3rd or 4th week of November in Barcelona (Spain). This Open Symposium has become a landmark for bioanalytical discussions in EU and has created a true Forum-like spirit where people meet and open discussions during sessions and presentations contribute to the development of an open mind in bioanalysis. For details of the meeting see https://bcn.e-b-f.eu .
Young Scientist Symposium: Since 2014, the EBF organizes an YSS on the day before the Open Symposium. The format was developed to create a development opportunity for young scientist to engage in international discussions. Creating a peer community of young scientists has been a proven recipe to lower the threshold for engagement in this community of young talents. For details of the meeting see www.yss.e-b-f.eu.
Managing the potential Covid-19 impact on the meeting:
The European Bioanalysis Forum VZW is continuously monitoring the Covid-19 situation and how this could impact (y)our plans for the 14th Open Symposium.
In absence of a crystal ball on what travel restrictions will look like around the time of our meeting, and without already having all the details at hand, we want to inform you of our current thinking and contingency planning for 14th Open Symposium.
- As a first contingency measure, which we are implementing today, we will be extending the deadline for submission of abstracts for oral presentations from end of May to mid-August. This should accommodate everybody’s immediate focus on their family and business-critical tasks in the current challenging environment.
- A second nd likely more impactful contingency measure is that we are developing a ‘plan B’ in case the international situation doesn’t allows unlimited and save travel for all. For now, ‘plan B’ is ‘work in progress’ and if we need to move to ‘plan B’ will be communicated around mid-June. At that time, we hope to have all the information at hand to plan safely in one or the other directions, i.e. an unchanged 14thOpen Symposium or ‘plan B’ = an alternative event. The latter will earmarked as the “13th EBF Open Symposium” (some may have picked up that we went from 12th to 14th Open Symposium in an attempt to defy fate 😊). We would still schedule in the same week as currently scheduled, albeit a smaller meeting in which we would still include all the ingredients adding value for the bioanalytical community as per our EBF mission.
- It may be appropriate to await booking of travel & lodging until it is clear what the travel situation is.